COMPASS Pathways plc (CMPS)
USD 3.09
(3.18%)
USD 3.09
(3.18%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 275.98 Million USD | 39.89% |
| 2022 | 197.29 Million USD | -34.43% |
| 2021 | 300.89 Million USD | 47.89% |
| 2020 | 203.45 Million USD | 528.16% |
| 2019 | 32.38 Million USD | 22.75% |
| 2018 | 26.38 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 278.53 Million USD | -9.86% |
| 2024 Q1 | 308.99 Million USD | 11.96% |
| 2024 Q3 | 247.33 Million USD | -11.2% |
| 2023 Q2 | 209.83 Million USD | 21.07% |
| 2023 FY | 275.98 Million USD | 39.89% |
| 2023 Q3 | 299.03 Million USD | 42.51% |
| 2023 Q4 | 275.98 Million USD | -7.71% |
| 2023 Q1 | 173.31 Million USD | -12.16% |
| 2022 Q3 | 224.52 Million USD | -5.92% |
| 2022 FY | 197.29 Million USD | -34.43% |
| 2022 Q2 | 238.63 Million USD | -12.3% |
| 2022 Q1 | 272.09 Million USD | -9.57% |
| 2022 Q4 | 197.29 Million USD | -12.13% |
| 2021 Q1 | 196.13 Million USD | -3.6% |
| 2021 Q3 | 314.74 Million USD | -6.09% |
| 2021 Q4 | 300.89 Million USD | -4.4% |
| 2021 Q2 | 335.16 Million USD | 70.88% |
| 2021 FY | 300.89 Million USD | 47.89% |
| 2020 Q2 | 77.07 Million USD | 200.63% |
| 2020 Q1 | 25.63 Million USD | -20.84% |
| 2020 FY | 203.45 Million USD | 528.16% |
| 2020 Q4 | 203.45 Million USD | -2.18% |
| 2020 Q3 | 207.99 Million USD | 169.85% |
| 2019 FY | 32.38 Million USD | 22.75% |
| 2019 Q4 | 32.38 Million USD | 0.0% |
| 2018 FY | 26.38 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 5.35 Billion USD | 94.85% |
| Addus HomeCare Corporation | 1.02 Billion USD | 73.059% |
| AirSculpt Technologies, Inc. | 213.55 Million USD | -29.236% |
| Amedisys, Inc. | 2.06 Billion USD | 86.604% |
| American Oncology Network, Inc. | 374.45 Million USD | 26.296% |
| Astrana Health, Inc. | 933.36 Million USD | 70.431% |
| Aveanna Healthcare Holdings Inc. | 1.63 Billion USD | 83.142% |
| IMAC Holdings, Inc. | 1.14 Million USD | -24022.229% |
| biote Corp. | 155.29 Million USD | -77.718% |
| Cryo-Cell International, Inc. | 61.22 Million USD | -350.806% |
| Cross Country Healthcare, Inc. | 679.31 Million USD | 59.373% |
| DocGo Inc. | 490.45 Million USD | 43.728% |
| The Ensign Group, Inc. | 4.17 Billion USD | 93.394% |
| Healthcare Services Group, Inc. | 803.18 Million USD | 65.638% |
| InnovAge Holding Corp. | 547.66 Million USD | 49.606% |
| Assure Holdings Corp. | 7.51 Million USD | -3572.97% |
| The Joint Corp. | 87.15 Million USD | -216.677% |
| LifeStance Health Group, Inc. | 2.23 Billion USD | 87.642% |
| Mobile-health Network Solutions Class A Ordinary Shares | 7.95 Million USD | -3371.266% |
| ModivCare Inc. | 1.76 Billion USD | 84.383% |
| NewGenIvf Group Limited | 1.64 Million USD | -16652.273% |
| Novo Integrated Sciences, Inc. | 35.56 Million USD | -676.05% |
| Option Care Health, Inc. | 3.32 Billion USD | 91.708% |
| P3 Health Partners Inc. | 860.96 Million USD | 67.945% |
| P3 Health Partners Inc. | 860.96 Million USD | 67.945% |
| The Pennant Group, Inc. | 539.69 Million USD | 48.862% |
| Surgery Partners, Inc. | 7.01 Billion USD | 96.068% |
| Syra Health Corp. Class A Common Stock | 4.92 Million USD | -5505.751% |
| Talkspace, Inc. | 142.22 Million USD | -94.055% |
| Talkspace, Inc. | 142.22 Million USD | -94.055% |
| The Oncology Institute, Inc. | 219.41 Million USD | -25.781% |
| The Oncology Institute, Inc. | 219.41 Million USD | -25.781% |